(Q39814049)

14 September 2017

title

Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. (English)

1 reference

14 September 2017

Meiyue Chen

1

1 reference

14 September 2017

Guangjie Chen

2

1 reference

14 September 2017

Hong Nie

3

1 reference

14 September 2017

Xin Zhang

4

1 reference

14 September 2017

Xiaoyin Niu

5

1 reference

14 September 2017

Ying C Q Zang

6

1 reference

14 September 2017

Sheri M Skinner

7

1 reference

14 September 2017

Jingwu Z Zhang

8

1 reference

14 September 2017

James M Killian

9

1 reference

14 September 2017

Jian Hong

10

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

European Journal of Immunology

14 September 2017

published in

1 reference

14 September 2017

volume

39

1 reference

14 September 2017

issue

9

1 reference

14 September 2017

page(s)

2525-2536

1 reference

Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

IFN-gamma induction of osteopontin expression in human monocytoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Role of osteopontin in amplification and perpetuation of rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Plasma osteopontin levels in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

A rush to judgment on Th17

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Alternative activation of STAT1 and STAT3 in response to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

T-bet-dependent expression of osteopontin contributes to T cell polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Multiple sclerosis: a complicated picture of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Transcriptional analysis of targets in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

New targets for treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Osteopontin polymorphisms and disease course in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

Interferon beta induces T-helper 2 immune deviation in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Transmigration of PBMNCs from beta-IFN-1b-treated MS patients: a one-year longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Chemotaxis of T lymphocytes on extracellular matrix proteins. Analysis of the in vitro method to quantitate chemotaxis of human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

An improved in vitro assay to quantitate chemotaxis of rat peripheral blood large granular lymphocytes (LGL)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838879

7 January 2021

Identifiers

DOI

10.1002/EJI.200838879

1 reference

14 September 2017

1 reference